ABOUT THIS PLATFORM
About Sulodexide.com
Date published: 2026-07-24 · Date last reviewed: 2026-07-24
Sulodexide.com is the public scientific platform of the Panacea Bio Chem Sulodexide research programme. The project is led by Bogdan Dicoias and investigates sulodexide as a complex glycosaminoglycan architecture operating at the intersection of the endothelial glycocalyx, coagulation, fibrinolysis, inflammation and vascular permeability. Sulodexide is an established international non-proprietary pharmaceutical substance. Panacea Bio Chem does not claim to have invented the original substance. Panacea is independently investigating its mechanisms, composition, analytical characterisation, formulation, stabilisation, processing and future vascular-repair potential. Sulodexide.com will document this programme and publish Panacea’s findings and scientific perspectives as they become available.
Editorial standard
Published findings, Panacea interpretations, programme directions and hypotheses are always distinguished by a visible evidence label. Citations are verified against PubMed or Crossref before display; negative and contradictory evidence is shown beside the positive.
Ownership
Sulodexide.com is owned and operated by Panacea Bio Chem Ltd. Sulodexide is an international non-proprietary pharmaceutical substance; this site does not claim ownership of the original substance or affiliation with its existing manufacturers.